SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.

Wider C, Vilariño-Güell C, Heckman MG, Jasinska-Myga B, Ortolaza-Soto AI, Diehl NN, Crook JE, Cobb SA, Bacon JA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2011 Jun;18(6):876-81. doi: 10.1111/j.1468-1331.2010.03297.x.

Analysis of EMG and acceleration signals for quantifying the effects of deep brain stimulation in Parkinson's disease.

Rissanen SM, Kankaanpää M, Tarvainen MP, Novak V, Novak P, Hu K, Manor B, Airaksinen O, Karjalainen PA.

IEEE Trans Biomed Eng. 2011 Sep;58(9):2545-53. doi: 10.1109/TBME.2011.2159380.

Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson's disease.

Foyet HS, Hritcu L, Ciobica A, Stefan M, Kamtchouing P, Cojocaru D.

J Ethnopharmacol. 2011 Jan 27;133(2):773-9. doi: 10.1016/j.jep.2010.11.011.

Body composition in premanifest Huntington's disease reveals lower bone density compared to controls.

Goodman AO, Barker RA.

Version 2. PLoS Curr. 2011 Feb 28 [revised 2011 Jan 1];3:RRN1214.

Acoustic assessment of voice and speech disorders in Parkinson's disease through quick vocal test.

Rusz J, Cmejla R, Růžičková H, Klempíř J, Majerová V, Picmausová J, Roth J, Růžička E.

Mov Disord. 2011 Aug 15;26(10):1951-2. doi: 10.1002/mds.23680. No abstract available.

[Psychiatric side effects of deep brain stimulation in Parkinson's disease].

Skuban T, Flohrer J, Klosterkötter J, Kuhn J.

Fortschr Neurol Psychiatr. 2011 Dec;79(12):703-10. doi: 10.1055/s-0031-1281854. Review. German.

In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson's disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model.

Soria G, Aguilar E, Tudela R, Mullol J, Planas AM, Marin C.

Eur J Neurosci. 2011 Apr;33(8):1551-60. doi: 10.1111/j.1460-9568.2011.07639.x.

Molecular biology of Huntington's disease.

McFarland KN, Cha JH.

Handb Clin Neurol. 2011;100:25-81. doi: 10.1016/B978-0-444-52014-2.00003-3. Review.

Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.

Kabuto H, Yamanushi TT.

Neurochem Res. 2011 Dec;36(12):2244-9. doi: 10.1007/s11064-011-0548-5.

Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson's disease.

Oyama G, Shimo Y, Natori S, Nakajima M, Ishii H, Arai H, Hattori N.

Parkinsonism Relat Disord. 2011 Mar;17(3):189-93. doi: 10.1016/j.parkreldis.2010.12.004.

Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.

Berendse HW, Roos DS, Raijmakers P, Doty RL.

J Neurol Sci. 2011 Nov 15;310(1-2):21-4. doi: 10.1016/j.jns.2011.06.020.

Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models.

Choi JG, Kim HG, Kim MC, Yang WM, Huh Y, Kim SY, Oh MS.

J Ethnopharmacol. 2011 Mar 24;134(2):414-21. doi: 10.1016/j.jep.2010.12.030.

Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.

Ojo OO, Oladipo OO, Ojini FI, Sanya EO, Danesi MA, Okubadejo NU.

West Afr J Med. 2011 Sep-Oct;30(5):319-24.

Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystonia.

Lange N, Hamann M, Shashidharan P, Richter A.

Pharmacol Biochem Behav. 2011 Feb;97(4):647-55. doi: 10.1016/j.pbb.2010.11.005.

The impact of attentional, auditory, and combined cues on walking during single and cognitive dual tasks in Parkinson disease.

Lohnes CA, Earhart GM.

Gait Posture. 2011 Mar;33(3):478-83. doi: 10.1016/j.gaitpost.2010.12.029.